Sharon Larkin
Directeur/Membre du Conseil chez SENSEONICS HOLDINGS, INC.
Fortune : 227 393 $ au 31/05/2024
Postes actifs de Sharon Larkin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SENSEONICS HOLDINGS, INC. | Directeur/Membre du Conseil | 08/12/2021 | - |
| Independent Dir/Board Member | 08/12/2021 | - | |
Senseonics, Inc.
 Senseonics, Inc. Electronic ComponentsElectronic Technology Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD. | Directeur/Membre du Conseil | 01/12/2021 | - |
Historique de carrière de Sharon Larkin
Anciens postes connus de Sharon Larkin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Directeur Administratif | 25/04/2017 | 01/01/2020 |
| Responsable des Ressources Humaines | 25/04/2017 | 01/01/2020 | |
| ABBOTT LABORATORIES | Responsable des Ressources Humaines | 01/09/2011 | 01/09/2015 |
Formation de Sharon Larkin
| Georgia Institute of Technology | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Director/Board Member | 2 |
| Human Resources Officer | 2 |
| Chief Administrative Officer | 1 |
Sectorielle
| Health Technology | 3 |
| Electronic Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| SENSEONICS HOLDINGS, INC. | Electronic Technology |
| Entreprise privées | 2 |
|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Senseonics, Inc.
Senseonics, Inc. Electronic ComponentsElectronic Technology Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD. | Electronic Technology |
- Bourse
- Insiders
- Sharon Larkin
- Expérience
